Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
A phase II study to evaluate the efficacy and safety profile of the combination of Pemetrexed
and Carboplatin in elderly patients with advanced non-small cell lung cancer